CN103272013A - Rheumatic arthritis treatment medicine and preparation method thereof - Google Patents

Rheumatic arthritis treatment medicine and preparation method thereof Download PDF

Info

Publication number
CN103272013A
CN103272013A CN2013102104833A CN201310210483A CN103272013A CN 103272013 A CN103272013 A CN 103272013A CN 2013102104833 A CN2013102104833 A CN 2013102104833A CN 201310210483 A CN201310210483 A CN 201310210483A CN 103272013 A CN103272013 A CN 103272013A
Authority
CN
China
Prior art keywords
medicine
rheumatic arthritis
parts
treatment
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2013102104833A
Other languages
Chinese (zh)
Inventor
武伟
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN2013102104833A priority Critical patent/CN103272013A/en
Publication of CN103272013A publication Critical patent/CN103272013A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a rheumatic arthritis treatment medicine. The medicine is prepared from raw materials such as eucommia ulmoides, radix angelicae pubescentis, radix clematidis, rhizoma atractylodis and safflower. The medicine can be prepared to form a plurality of forms for clinic use, and the preferential form of the medicine is oral liquid. The medicine soothes the liver, regulates the vital energy and can tonify the spleen and kidney, has a good curative effect on diseases such as rheumatic arthritis, can be clinically applied safely and reliably and does not have obvious toxic and side effects.

Description

A kind of medicine for the treatment of rheumatic arthritis and preparation method thereof
Technical field
The present invention relates to the medicine of a treatment of arthritis, specially referring to a kind of is the medicine of the treatment of arthritis of feedstock production with the Chinese herbal medicine, the invention still further relates to the preparation method of this medicine.
Background technology
In recent years, arthritis has become a kind of common disease of high incidence, and age of onset also more and more becomes younger, and rheumatic arthritis (rheumatoid arthritis) is a kind of common acute or chronic ICT.Can show effect repeatedly and involve heart.Clinical miserable with joint and muscle migration, heavily work, pain is feature.Belong to allergic disease.Be one of main performance of rheumatic fever, how with febris acuta and arthralgia onset.
Typical case's performance of rheumatic arthritis is slight or the moderate heating, migratory polyarthritis, the joint of getting involved mostly is big joint such as knee joint, ankle, shoulder, elbow wrist, commonly be transferred to another joint by a joint; the pathological changes part presents redness, scorching hot, severe pain part patient also has several joints to fall ill simultaneously; atypical patient only has arthralgia and do not have other inflammation performances, and acute inflammation generally disappears in 2-4 week and do not stay sequela, but the Chang Fanfu outbreak.If active rheumatism influences heart and myocarditis then can take place even leave over valve disorder.So should enhance your vigilance to arthritis, treatment as early as possible.
The arthritic medicine of western medicine is more at present, because doctor trained in Western medicine is not clear fully as yet to this sick mechanism, the most drug treatment is devoted to eliminate surperficial pain symptom, and these medicines and life-time service are all very big to the side effect of human body, the recurrence easily for the treatment of back usually is difficult to radical cure.
Summary of the invention
The present invention aims to provide a kind of multiple arthritic Chinese medicine that is applicable to, its therapeutic effect is good, and cost is low, and toxic and side effects is less.
The preparation method that this medicine is provided is another goal of the invention of the present invention.
Medicine of the present invention is to be made by following materials based on weight:
Cortex Eucommiae 10-20 part, Radix Angelicae Pubescentis 10-20 part, Radix Clematidis 10-20 part, Rhizoma Atractylodis 10-20 part, Flos Carthami 5-10 part.
The further quality proportioning of each component of medicine of the present invention is:
15 parts of the Cortexs Eucommiae, 15 parts of Radix Angelicae Pubescentiss, 15 parts of Radix Clematidis, 15 parts of Rhizoma Atractylodis, 8 parts on Flos Carthami.
Medicine of the present invention can be made into the described multiple dosage form of pharmaceutics, here with oral liquid as preferred dosage form.
The concrete preparation method of medicine of the present invention may further comprise the steps:
The raw material of getting above-mentioned mass fraction mixes, and adds the water of 2-4 times of dose, and water decocts after 20-40 minute and extracts filtrate, uses the method decocting 3 times, and get three filtrates and mix, sterilization, oral liquid is made in packing.
Traditional Chinese medical science traditional theory is thought " wind-cold damp pathogen, numbness resistance passages through which vital energy circulates causes passages through which vital energy circulates obstructed, stagnation of QI and blood may bring about pain ", so treatment by Chinese herbs generally is with expelling wind and cold, spasmolytic collateral dredging, activating blood circulation to dissipate blood stasis is purpose.All medicine reasonable compatibilities in the prescription of the present invention, complementary collaborative, dialectical treatment, depressed liver-energy dispersing and QI regulating, warming and recuperating the spleen and kidney has better curative effect for diseases such as rheumatic arthritis.
Actual efficacy for checking medicine of the present invention, use medicine of the present invention and cooperate clinical treatment arthritis patient 100, the result cures 83 examples, cure rate is 83%, 14 examples that are clearly better, total effective rate 97%, clinical test results proves, curative effect of medication of the present invention is definite, and has no side effect, and clinical practice is safe and reliable.Drug price of the present invention is comparatively cheap.
The specific embodiment
Embodiment 1:
Prepare raw material according to following weight:
The Cortex Eucommiae 11 kg, Radix Angelicae Pubescentis 11kg, Radix Clematidis 19kg, Rhizoma Atractylodis 19 kg, Flos Carthami 9kg.
The raw material of getting above-mentioned mass fraction mixes, and adds the water of 2-4 times of dose, and water decocts after 20-40 minute and extracts filtrate, uses the method decocting 3 times, and get three filtrates and mix, sterilization, oral liquid is made in packing.
Embodiment 2:
Prepare raw material according to following weight:
The Cortex Eucommiae 19 kg, Radix Angelicae Pubescentis 19kg, Radix Clematidis 11kg, Rhizoma Atractylodis 11 kg, Flos Carthami 6kg.
The raw material of getting above-mentioned mass fraction mixes, and adds the water of 2-4 times of dose, and water decocts after 20-40 minute and extracts filtrate, uses the method decocting 3 times, and get three filtrates and mix, sterilization, oral liquid is made in packing.

Claims (4)

1. medicine for the treatment of rheumatic arthritis is characterized in that described medicine is the medicament of being made by following materials based on weight:
Cortex Eucommiae 10-20 part, Radix Angelicae Pubescentis 10-20 part, Radix Clematidis 10-20 part, Rhizoma Atractylodis 10-20 part, Flos Carthami 5-10 part.
2. the medicine for the treatment of rheumatic arthritis according to claim 1 is characterized in that described medicine is the medicament of being made by following quality proportion raw material:
15 parts of the Cortexs Eucommiae, 15 parts of Radix Angelicae Pubescentiss, 15 parts of Radix Clematidis, 15 parts of Rhizoma Atractylodis, 8 parts on Flos Carthami.
3. the medicine for the treatment of rheumatic arthritis according to claim 1 and 2 is characterized in that described medicament is oral liquid.
4. the preparation method for the treatment of rheumatic arthritis medicine according to claim 3, it is characterized in that the raw material of getting above-mentioned mass fraction mixes, the water that adds 2-4 times of dose, water decocts after 20-40 minute and extracts filtrate, with the method decocting 3 times, get three filtrates and mix, sterilization, oral liquid is made in packing.
CN2013102104833A 2013-05-31 2013-05-31 Rheumatic arthritis treatment medicine and preparation method thereof Pending CN103272013A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2013102104833A CN103272013A (en) 2013-05-31 2013-05-31 Rheumatic arthritis treatment medicine and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2013102104833A CN103272013A (en) 2013-05-31 2013-05-31 Rheumatic arthritis treatment medicine and preparation method thereof

Publications (1)

Publication Number Publication Date
CN103272013A true CN103272013A (en) 2013-09-04

Family

ID=49054261

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2013102104833A Pending CN103272013A (en) 2013-05-31 2013-05-31 Rheumatic arthritis treatment medicine and preparation method thereof

Country Status (1)

Country Link
CN (1) CN103272013A (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003059370A1 (en) * 2002-01-18 2003-07-24 Pangenomics Co., Ltd. Crude drug compositions for treating or preventing arthritic diseases and the preparation process
CN101229245A (en) * 2008-01-28 2008-07-30 陈万田 Chinese traditional medicine for treating arthralgia, myalgia and numbness of extremities
CN101474322A (en) * 2009-02-06 2009-07-08 尹传海 Chinese medicinal liquor for treating wind-cold and rheumatic and preparation thereof
KR20100042337A (en) * 2008-10-16 2010-04-26 변정윤 The composition of traditional oriental medicines for reheumatoid arthritis and the method of preparing medicine for it
CN102824393A (en) * 2012-08-19 2012-12-19 甘肃省中医院 Pharmaceutical composition for dispelling wind, relieving pain, dispelling cold, and removing dampness and preparation method thereof

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003059370A1 (en) * 2002-01-18 2003-07-24 Pangenomics Co., Ltd. Crude drug compositions for treating or preventing arthritic diseases and the preparation process
CN101229245A (en) * 2008-01-28 2008-07-30 陈万田 Chinese traditional medicine for treating arthralgia, myalgia and numbness of extremities
KR20100042337A (en) * 2008-10-16 2010-04-26 변정윤 The composition of traditional oriental medicines for reheumatoid arthritis and the method of preparing medicine for it
CN101474322A (en) * 2009-02-06 2009-07-08 尹传海 Chinese medicinal liquor for treating wind-cold and rheumatic and preparation thereof
CN102824393A (en) * 2012-08-19 2012-12-19 甘肃省中医院 Pharmaceutical composition for dispelling wind, relieving pain, dispelling cold, and removing dampness and preparation method thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
王维: "《药酒大全》", 30 June 2006, article "红花威灵仙酒" *
苗明三等: "《对药的化学、药理与临床》", 30 April 2002, article "独活 苍术", pages: 233 *

Similar Documents

Publication Publication Date Title
CN101822813A (en) Medicine for treating gastric ulcer and preparation method thereof
CN103705849B (en) A kind of Chinese medicine for the treatment of bronchial asthma
CN101822780A (en) Medicament for treating oral ulcer and preparation method thereof
CN103550688B (en) A kind of Chinese medicine composition for the treatment of cardiopalmus
CN103446350A (en) Traditional Chinese medicine for treating chronic appendicitis
CN104771652A (en) Vertigo treating traditional Chinese medicine composition
CN108186749A (en) Treat Chinese medicine composition of cervical spondylosis and preparation method thereof
CN103893457A (en) Traditional Chinese medicine for treating ulcerative colitis
CN102784235A (en) Medicine for treating canker sores and preparation method thereof
CN101856423A (en) Medicament for treating menoxenia and preparation method thereof
CN102266451A (en) Medicament for treating infantile eczema and preparation method thereof
CN102085350A (en) Medicament for treating arthritis and preparation method thereof
CN103272013A (en) Rheumatic arthritis treatment medicine and preparation method thereof
CN103656463A (en) Traditional Chinese medicine for treating algomenorrhea
CN103330792B (en) Traditional Chinese medicine lotion for treating tinea pedes
CN103638474B (en) A kind of Chinese medicine for the treatment of atrophic gastritis
CN106075268A (en) A kind of Chinese medicine composition treating scabies
CN103656149A (en) Preparation method of traditional Chinese medicine prescription for treating insomnia
CN101428095A (en) Medicinal liquor for treating hemiplegia and preparation method thereof
CN104435979B (en) A kind of medicine for treating rheumatic lumbocrural pain pain
CN106581358A (en) Chinese medicine prescription for treating liver and stomach disharmony-type indigestion
CN102302593A (en) Medicament for treating gastritis and preparation method thereof
CN105288452A (en) Preparation method of medicine for treating jaundice
CN103356965A (en) Drug for curing rheumatoid arthritis
CN102406868B (en) Chinese medicine for treating rheumarthritis

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20130904